Metraipolis › archive › dc_69e59f59eccb
Development and Pharmacokinetic Evaluation of Newly Formulated Letrozole Non-Aqueous Nanoemulgel Transdermal Systems for Hormone-Dependent Breast Cancer Therapy — Europe PMC PMID:41304782
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41304782
- DOI
- 10.3390/pharmaceutics17111444
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T17:24:43.706Z
- SHA-256 of the archived text
b1744eb124543701b2cfd0dacd91669fbc54fad8d565afe60b6cd9bf5b38df60- Stable URL of this page
https://metraipolis.com/documento/dc_69e59f59eccb
How to cite
Development and Pharmacokinetic Evaluation of Newly Formulated Letrozole Non-Aqueous Nanoemulgel Transdermal Systems for Hormone-Dependent Breast Cancer Therapy — Europe PMC PMID:41304782 — Europe PMC (en), https://europepmc.org/article/MED/41304782 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69e59f59eccb (Metraipolis archive dc_69e59f59eccb, sha256 b1744eb124543701b2cfd0dacd91669fbc54fad8d565afe60b6cd9bf5b38df60)
BibTeX
@misc{dc69e59f59eccb,
title = {Development and Pharmacokinetic Evaluation of Newly Formulated Letrozole Non-Aqueous Nanoemulgel Transdermal Systems for Hormone-Dependent Breast Cancer Therapy — Europe PMC PMID:41304782},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41304782},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69e59f59eccb; sha256 b1744eb124543701b2cfd0dacd91669fbc54fad8d565afe60b6cd9bf5b38df60},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304782. Agents can read the archived copy with the MCP tool read_document.